In an H9C2 cardiac hypertrophy model induced by high glucose, LCA reduces the mRNA levels of hypertrophic markers such as calcineurin (CaN) and nuclear factor of activated T-cells (NFAT) in a dose-dependent manner (Cheng et al., 2019). The gene discussed is NUP214; the disease is cardiac hypertrophy.